...

Tuberculosis Pipeline Landscape and Therapeutics Market Review for H2 2016

by Industry Analysis

on
8

views

Report

Comments

Description

Tuberculosis, commonly known as TB, is a bacterial infection that can spread through the lymph nodes and bloodstream to any organ in body. It is most often found in the lungs. The symptoms of tuberculosis range from no symptoms (latent tuberculosis) to symptoms of active disease. Symptoms include overall sensation of feeling unwell; cough, possibly with bloody mucus, fatigue, shortness of breath, weight loss and pain in the chest. Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Tuberculosis Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Tuberculosis (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

Transcript

Tuberculosis Pipeline Landscape and Therapeutics Market Review for H2 2016
Tuberculosis Pipeline Landscape and Therapeutics
Market Review for H2 2016
No of Pages – 393
Publishing Date - November, 2016
Browse detailed TOC, Tables, Figures, and Charts in Global Serial Device Server Consumption
2016 Market Research Report at:
http://www.marketresearchhub.com/report/tuberculosis-pipeline-review-h2-2016report.html
Tuberculosis, commonly known as TB, is a bacterial infection that can spread through the lymph
nodes and bloodstream to any organ in body. It is most often found in the lungs. The symptoms
of tuberculosis range from no symptoms (latent tuberculosis) to symptoms of active disease.
Symptoms include overall sensation of feeling unwell; cough, possibly with bloody mucus, fatigue,
shortness of breath, weight loss and pain in the chest.
Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide
Tuberculosis Pipeline Review, H2 2016, provides comprehensive information on the
therapeutics under development for Tuberculosis (Infectious Disease), complete with
analysis by stage of development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type.
Table of Contents
Introduction 7
Tuberculosis Overview 8
Therapeutics Development 9
Tuberculosis - Therapeutics under Development by Companies 11
Tuberculosis - Therapeutics under Investigation by Universities/Institutes 16
Tuberculosis - Pipeline Products Glance 19
Tuberculosis - Products under Development by Companies 23
Tuberculosis - Products under Investigation by Universities/Institutes 30
Tuberculosis - Companies Involved in Therapeutics Development 35
Tuberculosis - Therapeutics Assessment 99
Drug Profiles 111
Tuberculosis - Dormant Projects 345
Tuberculosis - Discontinued Products 356
Tuberculosis - Product Development Milestones 357
Appendix 371
List of Tables
Number of Products under Development for Tuberculosis, H2 2016 30
Number of Products under Development for Tuberculosis - Comparative Analysis,
H2 2016 31
Number of Products under Development by Companies, H2 2016 32
Number of Products under Development by Companies, H2 2016 (Contd..1) 33
Number of Products under Development by Companies, H2 2016 (Contd..2) 34
Number of Products under Development by Companies, H2 2016 (Contd..3) 35
Number of Products under Development by Companies, H2 2016 (Contd..4) 36
Number of Products under Investigation by Universities/Institutes, H2 2016 37
Number of Products under Investigation by Universities/Institutes, H2 2016
(Contd..1) 38
Number of Products under Investigation by Universities/Institutes, H2 2016
(Contd..2) 39
Comparative Analysis by Late Stage Development, H2 2016 40
Comparative Analysis by Clinical Stage Development, H2 2016 41
Comparative Analysis by Early Stage Development, H2 2016 42
Comparative Analysis by Unknown Stage Development, H2 2016 43
Request for Free Sample Report
List of Figures
Number of Products
Number of Products
Number of Products
Number of Products
under
under
under
under
Development for Tuberculosis, H2 2016 30
Development for Tuberculosis - Comparative Analysis, H2 2016 31
Development by Companies, H2 2016 32
Investigation by Universities/Institutes, H2 2016 37
Comparative Analysis by Late Stage Development, H2 2016 40
Comparative Analysis by Clinical Stage Development, H2 2016 41
Comparative Analysis by Early Stage Products, H2 2016 42
Assessment by Monotherapy Products, H2 2016 120
Assessment by Combination Products, H2 2016 121
Report Details –
Date of Publishing – November, 2016
No of Pages – 393
Single User License – $2000
Multiple User License – $4000
Buy Report Now!
About Market Research HUB : Market Research HUB is the credible source for gaining the
market research reports that will exponentially accelerate your business. We are among the
leading report resellers in the business world committed towards optimizing your business. The
reports we provide are based on a research that covers a magnitude of factors such as
technological evolution, economic shifts and a detailed study of market segments.
Contact–
90 State Street,
Albany, NY 12207,
United States
Toll Free : 866-997-4948 (US-Canada)
Tel : +1-518-621-2074
Email : mailto:sales@marketresearchhub.com
Website : http://www.marketresearchhub.com/
Fly UP